Articles from Leinco Technologies, Inc.
Strategic Partnership Combines Leinco’s Manufacturing Capabilities with IHC and Spatial Biology Validated Antibody Portfolio, plus CellCarta’s CPTAC validated Immuno-MRM Resources to Enhance Clinical Research and Biomarker Discovery
By Leinco Technologies, Inc. · Via GlobeNewswire · April 23, 2026
